Natural Alternatives International Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Net Sales Quarterly35.5M
Private-Label Contract Manufacturing Sales Quarterly33.8M
CarnoSyn Beta-Alanine Royalty, Licensing and Raw Material Sales Quarterly17M
Watch Items
- Factory Capacity UtilizationTrigger: Persistent underutilization leading to operating lossesAction: Monitor customer order forecasts and adjust production shifts or furlough programs accordingly.
- Credit Facility Covenants and LiquidityTrigger: Transition to Legacy Corporate Lending, LLC facilityAction: Track compliance with the new $11.0 million term loan and $20.0 million working capital line covenants.
Research as of 20 Jun 2026